klow peptide klow (BPC-157 + TB-500 + GHK-Cu + KPV) KLOW Dosing Guide: GHK-Cu +

Patients with high visceral fat, insulin resistance, stubborn abdominal fat that does not respond to diet and exercise, and low lean muscle mass tend to respond best

As NAD+ declines with age, sirtuin activity is reduced, compromising all downstream functions

It may improve immune responses, help to metabolize toxins and activate enzymes, aid the liver in metabolizing alcohol, reduce the amount of fat stored in the belly, help to reduce oxidative stress and improve complexion

Achieving the same IGF-1 induction with lower serum GH levels has the potential to maintain efficacy of treatment while reducing the risk of side effects due to the direct actions of hGH